Psychic and somatic anxiety symptom burden and functional remission in generalized anxiety disorder

被引:0
|
作者
Mychaskiw, M. A. [1 ]
Hoffman, D. L. [2 ]
Dodge, W. E. [1 ]
Herman, B. K. [1 ]
机构
[1] Pfizer Inc, Pfizer Global Pharmaceut, New York, NY USA
[2] Pfizer Inc, Pfizer Global Res & Dev, New London, CT USA
关键词
D O I
10.1016/S0924-977X(08)70732-6
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:S489 / S490
页数:2
相关论文
共 50 条
  • [21] The Role of Health Anxiety for Emotion Regulation in Somatic Symptom Disorder
    Martin, A.
    Gitzen, H.
    JOURNAL OF PSYCHOSOMATIC RESEARCH, 2017, 97 : 160 - 160
  • [22] Meta-analysis of the comparative efficacy of benzodiazepines and antidepressants for psychic versus somatic symptoms of generalized anxiety disorder
    Beyer, Chad
    Currin, Christopher B.
    Williams, Taryn
    Stein, Dan J.
    COMPREHENSIVE PSYCHIATRY, 2024, 132
  • [23] Predictors of remission from generalized anxiety disorder and major depressive disorder
    Kelly, Kristen M.
    Mezuk, Briana
    JOURNAL OF AFFECTIVE DISORDERS, 2017, 208 : 467 - 474
  • [24] Is generalized anxiety disorder a chronic disorder? Predicting chronicity and spontaneous remission
    Beesdo, K
    Wittchen, HU
    Hoefler, M
    Pfister, H
    Bittner, A
    Lieb, R
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2004, 14 : S310 - S310
  • [25] Trait anxiety mediates the association between hippocampal-insula functional connectivity and anxiety symptom severity in adults with and without generalized anxiety disorder
    Liu, Shiyu
    Cao, Lingxiao
    Li, Hailong
    Du, Yang
    Wang, Mei
    Xiao, Hongqi
    Duan, Yingxu
    Deng, Gaoju
    Huang, Xiaoqi
    Qiu, Changjian
    Gong, Qiyong
    JOURNAL OF AFFECTIVE DISORDERS, 2024, 344 : 1 - 7
  • [26] Generalized anxiety disorder: Prevalence, burden, and cost to society
    Wittchen, HU
    DEPRESSION AND ANXIETY, 2002, 16 (04) : 162 - 171
  • [27] Generalized Anxiety Disorder: Epidemiology, Burden, and Comorbid Depression
    Cabanac, Annie Druet
    Simon, Virginie
    Offredo, Lucile
    Azzi, Jessica
    Lucchino, Marco
    Hood, Sean
    Briere, Jean Baptiste
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 : 290 - 290
  • [28] Psychic and somatic anxiety symptoms as predictors of response to fluoxetine in major depressive disorder
    Papakostas, George I.
    McGrath, Patrick
    Stewart, Jonathan
    Charles, Dana
    Chen, Ying
    Mischoulon, David
    Dording, Christina
    Fava, Maurizio
    PSYCHIATRY RESEARCH, 2008, 161 (01) : 116 - 120
  • [29] The efficacy of pregabalin in achieving remission in outpatients with generalized anxiety disorder
    Wittchen, H. U.
    Baldinetti, F.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2006, 9 : S119 - S120
  • [30] Overview of different pharmacotherapies for attaining remission in generalized anxiety disorder
    Ballenger, JC
    JOURNAL OF CLINICAL PSYCHIATRY, 2001, 62 : 11 - 19